Literature DB >> 23166874

Tissue factor with age-related macular degeneration.

Guan-Feng Wang1, Xiu-Lan Zou.   

Abstract

Wet age-related macular degeneration which incidence increases year by year is a blinding eye disease, but current clinical methods of treatment on this disease are limited and the outcome is not ideal. Recent studies have found abnormally high expression of tissue factors which are targets for the treatment of wet age-related macular degeneration to achieve a certain effect in the choroidal neovascularization. Related literatures are reviewed as following.

Entities:  

Keywords:  choroidal neovascularzation; immunotherapy; photodynamic therapy; tissue factor; wet age-related macular degeneration

Year:  2012        PMID: 23166874      PMCID: PMC3484712          DOI: 10.3980/j.issn.2222-3959.2012.05.13

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  29 in total

Review 1.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

Authors:  Jayakrishna Ambati; Balamurali K Ambati; Sonia H Yoo; Sean Ianchulev; Anthony P Adamis
Journal:  Surv Ophthalmol       Date:  2003 May-Jun       Impact factor: 6.048

2.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 3.  Current perspective on the role of apoptosis in atherothrombotic disease.

Authors:  Z Mallat; A Tedgui
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

4.  Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

Authors:  Puran S Bora; Zhiwei Hu; Tongalp H Tezel; Jeong-Hyeon Sohn; Shin Goo Kang; Jose M C Cruz; Nalini S Bora; Alan Garen; Henry J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

Review 5.  Intertwining of thrombosis and inflammation in atherosclerosis.

Authors:  Kevin Croce; Peter Libby
Journal:  Curr Opin Hematol       Date:  2007-01       Impact factor: 3.284

6.  Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1.

Authors:  Udo Bavendiek; Peter Libby; Meagan Kilbride; Rebecca Reynolds; Nigel Mackman; Uwe Schönbeck
Journal:  J Biol Chem       Date:  2002-04-26       Impact factor: 5.157

7.  Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.

Authors:  Hans E Grossniklaus; Jun X Ling; Timothy M Wallace; Stefan Dithmar; Diane H Lawson; Cynthia Cohen; Victor M Elner; Susan G Elner; Paul Sternberg
Journal:  Mol Vis       Date:  2002-04-21       Impact factor: 2.367

8.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.

Authors:  Roger G Fahmy; Crispin R Dass; Lun-Quan Sun; Colin N Chesterman; Levon M Khachigian
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

9.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling.

Authors:  Mattias Belting; Michael I Dorrell; Staffan Sandgren; Edith Aguilar; Jasimuddin Ahamed; Andrea Dorfleutner; Peter Carmeliet; Barbara M Mueller; Martin Friedlander; Wolfram Ruf
Journal:  Nat Med       Date:  2004-04-18       Impact factor: 53.440

10.  Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.

Authors:  Tongalp H Tezel; Ewa Bodek; Kenan Sönmez; Sankar Kaliappan; Henry J Kaplan; Zhiwei Hu; Alan Garen
Journal:  Ocul Immunol Inflamm       Date:  2007 Jan-Feb       Impact factor: 3.070

View more
  4 in total

1.  Protection of tight junction between RPE cells with tissue factor targeting peptide.

Authors:  Xiu-Lan Zou; Guan-Feng Wang; Dan-Dan Li; Jing-Xia Chen; Chun-Li Zhang; Yong-Zhen Yu; Wen-Jie Zhou; Yu-Ping Zou; Ben-Qiang Rao
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

2.  RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells.

Authors:  George Inana; Christopher Murat; Weijun An; Xiang Yao; Ian R Harris; Jing Cao
Journal:  J Transl Med       Date:  2018-03-13       Impact factor: 5.531

Review 3.  The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health.

Authors:  Declan Timothy Waugh
Journal:  Int J Environ Res Public Health       Date:  2019-03-08       Impact factor: 3.390

Review 4.  New Therapies of Neovascular AMD-Beyond Anti-VEGFs.

Authors:  Praveen Yerramothu
Journal:  Vision (Basel)       Date:  2018-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.